stoxline Quote Chart Rank Option Currency Glossary
  
DarioHealth Corp. (DRIO)
1.53  0.01 (0.66%)    03-28 16:00
Open: 1.45
High: 1.66
Volume: 164,418
  
Pre. Close: 1.52
Low: 1.42
Market Cap: 42(M)
Technical analysis
2024-03-28 4:50:53 PM
Short term     
Mid term     
Targets 6-month :  2.22 1-year :  2.63
Resists First :  1.9 Second :  2.25
Pivot price 1.53
Supports First :  1.32 Second :  1.09
MAs MA(5) :  1.5 MA(20) :  1.59
MA(100) :  1.71 MA(250) :  2.71
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  36.6 D(3) :  32.2
RSI RSI(14): 41.1
52-week High :  4.57 Low :  0.68
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ DRIO ] has closed above bottom band by 48.3%. Bollinger Bands are 47.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.66 - 1.67 1.67 - 1.67
Low: 1.41 - 1.41 1.41 - 1.42
Close: 1.52 - 1.53 1.53 - 1.54
Company Description

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Headline News

Thu, 28 Mar 2024
DarioHealth Corp. (DRIO) Q4 2023 Earnings Call Transcript - Seeking Alpha

Thu, 28 Mar 2024
Dario Health Corp Down 2.63% To $1.48 After Earnings - InvestorsObserver

Tue, 26 Mar 2024
DarioHealth (DRIO) to Release Quarterly Earnings on Thursday - Defense World

Thu, 21 Mar 2024
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH - PR Newswire

Thu, 22 Feb 2024
DarioHealth Corp Unveils Updated Investor Presentation - TipRanks.com - TipRanks

Wed, 21 Feb 2024
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic ... - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 28 (M)
Shares Float 21 (M)
Held by Insiders 17.1 (%)
Held by Institutions 31.8 (%)
Shares Short 1,110 (K)
Shares Short P.Month 882 (K)
Stock Financials
EPS -2.04
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.5
Profit Margin -245.4 %
Operating Margin -441.9 %
Return on Assets (ttm) -27.4 %
Return on Equity (ttm) -73.6 %
Qtrly Rev. Growth -46.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.84
EBITDA (p.s.) -1.66
Qtrly Earnings Growth 0 %
Operating Cash Flow -31 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -0.75
PEG Ratio 0
Price to Book value 0.61
Price to Sales 1.8
Price to Cash Flow -1.38
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android